Heidelberg Pharma AG (HPHA)
Market Closed
11 Aug, 15:30
€
2. 53
+0.03
+1.2%
€
- Market Cap
- P/E Ratio
- Div Yield
2,147 Volume
- Eps
€ 2.5
Previous Close Want to track HPHA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.31 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
HPHA Earnings Reports FAQ
What is the earnings per share (EPS) for HPHA?
EPS data for HPHA is currently not available, as Heidelberg Pharma AG has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 13 years, the earnings growth rate has been approximately -45.57%, reflecting the HPHA's performance and XETRA market conditions.
When is the next earnings release date?
Heidelberg Pharma AG has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Heidelberg Pharma AG are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for HPHA at this time, as Heidelberg Pharma AG has no recent EPS data to calculate it.
